Press coverage about MYOS RENS Technology (NASDAQ:MYOS) has trended somewhat positive this week, Accern Sentiment reports. Accern identifies negative and positive media coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. MYOS RENS Technology earned a coverage optimism score of 0.24 on Accern’s scale. Accern also gave media headlines about the company an impact score of 43.7617704383955 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.
Shares of MYOS RENS Technology (NASDAQ MYOS) opened at 1.71 on Tuesday. The stock’s market capitalization is $9.99 million. MYOS RENS Technology has a 1-year low of $1.02 and a 1-year high of $6.98. The stock has a 50 day moving average price of $1.87 and a 200-day moving average price of $2.53.
Separately, ValuEngine upgraded MYOS RENS Technology from a “strong sell” rating to a “sell” rating in a report on Thursday, July 6th.
TRADEMARK VIOLATION WARNING: This piece was first published by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this piece can be accessed at https://stocknewstimes.com/2017/08/08/myos-rens-technology-myos-receiving-somewhat-favorable-news-coverage-analysis-shows-updated-updated.html.
MYOS RENS Technology Company Profile
MYOS RENS Technology Inc (MYOS), formerly MYOS Corporation, is an early-stage bionutrition and biotherapeutics company. The Company is focused on the discovery, development and commercialization of products that improve muscle health and function essential for the management of sarcopenia, cachexia and degenerative muscle diseases, and as an adjunct to the treatment of obesity.
Receive News & Ratings for MYOS RENS Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MYOS RENS Technology Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
